Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Working Capital Turnover

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Working-Capital-Turnover" stands at 9.84 as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Working Capital Turnover" stands at 9.84. This represents a decrease of -7.68 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.94 percent compared to the value the year prior.
The 1 year change in percent is -7.94.
The 3 year change in percent is 21.58.

The Serie's long term average value is 23.73. It's latest available value, on 09/30/2025, is 58.54 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +71.34%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 09/30/2025, is -92.48%.

Working Capital Turnover for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Working Capital Turnover905,699,262,464.00
LogoJohnson & Johnson - Working Capital Turnover486,508,953,600.00
LogoAbbVie Inc - Working Capital Turnover399,570,305,024.00
LogoRoche Holding AG - Working Capital Turnover317,433,206,677.55
LogoAstraZeneca PLC - Working Capital Turnover280,205,508,085.11